600587 Shinva Medical Instrument
- 22.44
- +0.16+0.72%
Shinva Medical Instrument News
Xinhua Medical\'s 2023 Accounting Firm Performance Assessment Report
Special Opinions of the Board of Directors of Xinhua Healthcare on the Independence of Independent Directors
Announcement of Xinhua Medical on Proposed Renewal of Financial Audit Institutions and Internal Control Auditors for 2024
Xinhua Medical External Guarantee Notice
CITIC Construction Investment Securities Co., Ltd.'s inspection opinion on the external guarantee of Shandong Xinhua Medical Devices Co., Ltd.
Xinhua Medical\'s announcement on changes in accounting policies
Resolutions of the 10th Meeting of the 11th Board of Directors of Xinhua Healthcare
CITIC Construction Investment Securities Co., Ltd. annual report on the continuous supervision of Shandong Xinhua Medical Devices Co., Ltd. in 2023
Announcement of Resolutions of the 10th Meeting of the 11th Board of Directors of Xinhua Medical
Resolutions of the 10th Meeting of the 11th Board of Directors of Xinhua Healthcare
Prior approval opinions of independent directors of Xinhua Healthcare on proposals relating to the 10th meeting of the 11th Board of Directors
Xinhua Medical Independent Director Work System
Announcement of Resolutions of the 10th Meeting of the 11th Board of Supervisors of Xinhua Medical
CITIC Construction Investment Securities Co., Ltd.\'s inspection opinions on Shandong Xinhua Medical Devices Co., Ltd.\'s daily related transactions in 2023 and expected daily related transactions in 2024
Xinhua Healthcare 2023 Annual Audit Report
Announcement on daily related transactions of Xinhua Healthcare
Xinhua Medical\'s special report on the storage and actual use of funds raised by the company
Independent Opinions of Independent Directors of Xinhua Healthcare on the Proposals Related to the 10th Meeting of the 11th Board of Directors
Special audit report on the summary table of non-operating capital occupation of Xinhua Medical and other related capital transactions
Xinhua Healthcare 2023 Independent Director Debriefing Report (Gu Weijun)
Analysis
Price Target
No Data
